Company Overview
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Company Information
- CEO
- Brian S. Tyler
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 44000
Contact Information
- Website
- https://www.mckesson.com
- Address
- 6555 State Highway 161
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 83.16B market capitalization
- Trading Volume: 1.30M shares traded today
- Price Range: 52-week range of $464.42 - $737.89
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for McKesson Corporation
McKesson Corporation (MCK) operates in the Medical - Distribution industry within the Healthcare sector. With a current market capitalization of 83.16B, the company represents a significant player in its market. The stock is currently trading at $668.58 with a positivedaily change of 0.80%.
The company's 44000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 26.81, beta of 0.50, and 52-week price range from $464.42 to $737.89when evaluating investment opportunities.
Why Invest in McKesson Corporation?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Brian S. Tyler
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.